Form 4: Centene Director Jessica Blume Receives Equity Grant

Centene Corporation Director Jessica Blume acquired 3,992 restricted stock units as part of an annual equity award.

Summary

• Director Jessica L. Blume was granted 3,992 restricted stock units (RSUs) on May 12, 2026.
• The grant was issued at a price of $0 per share as part of a standard equity compensation arrangement.
• Following this transaction, Ms. Blume's direct beneficial ownership in Centene Corporation (CNC) increased to 32,357 shares.
• Ms. Blume maintains an additional indirect holding of 250 shares held in a revocable family trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• The equity grant aligns the director's interests with those of shareholders through increased stock ownership.

Negatives

• None identified.

Risks

• The vesting of the 3,992 RSUs is contingent upon the earlier of May 12, 2027, or the date of the next annual meeting of stockholders.

Future Outlook

The restricted stock units are scheduled to vest in full on May 12, 2027, or upon the date of the next annual meeting of stockholders, whichever occurs first.

Industry Context

StockSavvy.ai notes that director equity grants are standard corporate governance practices designed to ensure long-term alignment between board members and shareholders in the managed care industry.

Comparison to Industry Standards

• The grant of restricted stock units to non-employee directors is consistent with compensation practices at peer healthcare organizations such as UnitedHealth Group and Elevance Health.

Stakeholder Impact

• Increased alignment between board oversight and shareholder interests.

Next Steps

• Vesting of the 3,992 restricted stock units on May 12, 2027, or the next annual meeting date.

Key Dates

Keywords

Centene, CNC, Form 4, Insider Trading, Equity Grant, Director Compensation